- ￥2000 - 8000
- 湖北省武汉市
- Rat Slc10a7重组蛋白表达
- 2025年09月11日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 服务名称：
Rat Slc10a7重组蛋白表达
- 提供商：
普健生物（武汉）科技有限公司
Uniprot号：Q5PT50
基因名：Slc10a7
蛋白名：Sodium
蛋白别名：
Sodium, +, Solute carrier family 10 member 7
服务内容：
| 服务项目 | 客户提供 | 服务内容 | 服务周期 | 交付内容 |
|---|---|---|---|---|
| 大肠杆菌系统 蛋白表达 |
基因序列 | 方案沟通 | 1天 | 方案报告 |
| 密码子优化和基因合成 | 5天 | 基因合成报告 | ||
| 表达纯化测试 | 3天 | 表达纯化测试报告 | ||
| 1L表达及纯化 | 3天 | 蛋白样品(3-5mg)及报告 | ||
| 放大发酵及纯化 | 7天 | 纯化的蛋白及报告 |
案例展示：
Slc10a7相关研究文献：
1. SLC10A7, an orphan member of the SLC10 family involved in congenital disorders of glycosylation. [34999954]
2. Identification of novel homozygous nonsense SLC10A7 variant causing short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis and surgical management of spine. [38037133]
3. SLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defects. [30082715]
4. The orphan solute carrier SLC10A7 is a novel negative regulator of intracellular calcium signaling. [32350310]
5. SLC10A7 regulates O-GalNAc glycosylation and Ca(2+) homeostasis in the secretory pathway: insights into SLC10A7-CDG. [39779512]
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验2. Identification of novel homozygous nonsense SLC10A7 variant causing short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis and surgical management of spine. [38037133]
3. SLC10A7 mutations cause a skeletal dysplasia with amelogenesis imperfecta mediated by GAG biosynthesis defects. [30082715]
4. The orphan solute carrier SLC10A7 is a novel negative regulator of intracellular calcium signaling. [32350310]
5. SLC10A7 regulates O-GalNAc glycosylation and Ca(2+) homeostasis in the secretory pathway: insights into SLC10A7-CDG. [39779512]
技术资料暂无技术资料 索取技术资料
